+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

Eye Allergy Therapeutics Market Report 2025 - Product Thumbnail Image

Eye Allergy Therapeutics Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Intranasal Corticosteroids Market Report 2025 - Product Thumbnail Image

Intranasal Corticosteroids Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Nasal Corticosteroids Market Report 2025 - Product Thumbnail Image

Nasal Corticosteroids Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Aspirin Market Report 2025 - Product Thumbnail Image

Aspirin Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Rheumatoid Arthritis Drugs Market Report 2025 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Hydroxychloroquine Market Report 2025 - Product Thumbnail Image

Hydroxychloroquine Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Ibuprofen Arginine API Market - Global Forecast to 2030 - Product Thumbnail Image

Ibuprofen Arginine API Market - Global Forecast to 2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
From
From
Psoriatic Arthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Still's Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Still's Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Plaque Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Toll-like Receptor 9 (TLR-9) Modulator - Pipeline Insight, 2025 - Product Thumbnail Image

Toll-like Receptor 9 (TLR-9) Modulator - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
From
Toll-Like Receptor Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

Toll-Like Receptor Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Treg Cell-Based Therapies - Pipeline Insight, 2025 - Product Thumbnail Image

Treg Cell-Based Therapies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Endometriosis- Pipeline Insight, 2025 - Product Thumbnail Image

Endometriosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more